Switch to:
Also traded in: Canada, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.40
HLTH's Cash to Debt is ranked higher than
50% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. HLTH: 0.40 )
Ranked among companies with meaningful Cash to Debt only.
HLTH' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 4.06 Max: No Debt
Current: 0.4
Equity to Asset 0.55
HLTH's Equity to Asset is ranked higher than
60% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. HLTH: 0.55 )
Ranked among companies with meaningful Equity to Asset only.
HLTH' s Equity to Asset Range Over the Past 10 Years
Min: -0.73  Med: 0.40 Max: 0.81
Current: 0.55
-0.73
0.81
Interest Coverage 10.09
HLTH's Interest Coverage is ranked higher than
61% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 6.34 vs. HLTH: 10.09 )
Ranked among companies with meaningful Interest Coverage only.
HLTH' s Interest Coverage Range Over the Past 10 Years
Min: 19.82  Med: 9999.00 Max: 9999.99
Current: 10.09
19.82
9999.99
F-Score: 5
Z-Score: 2.32
M-Score: -0.76
WACC vs ROIC
11.60%
46.18%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 7.77
HLTH's Operating margin (%) is ranked higher than
52% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 7.16 vs. HLTH: 7.77 )
Ranked among companies with meaningful Operating margin (%) only.
HLTH' s Operating margin (%) Range Over the Past 10 Years
Min: -89.06  Med: 14.49 Max: 64.77
Current: 7.77
-89.06
64.77
Net-margin (%) 21.44
HLTH's Net-margin (%) is ranked higher than
91% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 4.71 vs. HLTH: 21.44 )
Ranked among companies with meaningful Net-margin (%) only.
HLTH' s Net-margin (%) Range Over the Past 10 Years
Min: -243.59  Med: -5.29 Max: 22.18
Current: 21.44
-243.59
22.18
ROE (%) 59.04
HLTH's ROE (%) is ranked higher than
98% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 9.62 vs. HLTH: 59.04 )
Ranked among companies with meaningful ROE (%) only.
HLTH' s ROE (%) Range Over the Past 10 Years
Min: -169.82  Med: -11.14 Max: 63.67
Current: 59.04
-169.82
63.67
ROA (%) 29.31
HLTH's ROA (%) is ranked higher than
98% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 3.86 vs. HLTH: 29.31 )
Ranked among companies with meaningful ROA (%) only.
HLTH' s ROA (%) Range Over the Past 10 Years
Min: -114.87  Med: -8.75 Max: 30.76
Current: 29.31
-114.87
30.76
ROC (Joel Greenblatt) (%) 56.50
HLTH's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 18.36 vs. HLTH: 56.50 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HLTH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -442.51  Med: 72.43 Max: 266.35
Current: 56.5
-442.51
266.35
Revenue Growth (3Y)(%) 93.40
HLTH's Revenue Growth (3Y)(%) is ranked higher than
99% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. HLTH: 93.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HLTH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -51.2  Med: -21.70 Max: 188
Current: 93.4
-51.2
188
EBITDA Growth (3Y)(%) 70.80
HLTH's EBITDA Growth (3Y)(%) is ranked higher than
97% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. HLTH: 70.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HLTH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.4  Med: 41.25 Max: 128.4
Current: 70.8
-61.4
128.4
EPS Growth (3Y)(%) 215.50
HLTH's EPS Growth (3Y)(%) is ranked higher than
99% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. HLTH: 215.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HLTH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -80.2  Med: 52.95 Max: 215.5
Current: 215.5
-80.2
215.5
» HLTH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

HLTH Guru Trades in Q2 2015

Chuck Royce 292,300 sh (New)
Jim Simons 20,200 sh (New)
» More
Q3 2015

HLTH Guru Trades in Q3 2015

Chuck Royce 366,600 sh (+25.42%)
Jim Simons Sold Out
» More
Q4 2015

HLTH Guru Trades in Q4 2015

Jim Simons 95,600 sh (New)
Chuck Royce 960,700 sh (+162.06%)
» More
Q1 2016

HLTH Guru Trades in Q1 2016

Jim Simons 157,500 sh (+64.75%)
Chuck Royce 1,235,700 sh (+28.62%)
» More
» Details

Insider Trades

Latest Guru Trades with HLTH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:BIOS, NYSE:CCM, NAS:USMD, OTCPK:CMBGF, NAS:ADUS, OTCPK:FDNH, OTCPK:CATS, OTCPK:CVHIF, NYSE:QHC, OTCPK:AMEH, NAS:JYNT, OTCPK:FCHS, OTCPK:CCEL, OTCPK:BNKL, OTCPK:BRRZY, OTCPK:AGHEF, AMEX:HH, AMEX:AMS, OTCPK:PFHO, OTCPK:WNDM » details
Traded in other countries:NHC.Canada, NH1.Germany,
Nobilis Health Corp is a healthcare development and management company. It is engaged in development and management of ambulatory surgical centers providing medical care & healthcare delivery services.

Northstar Healthcare, Inc. partners with the physicians in the development and management of ambulatory surgery centres in the United States. It manages an ambulatory surgery centre in Dallas and two pain management clinics in Houston.

Ratios

vs
industry
vs
history
P/E(ttm) 3.60
HLTH's P/E(ttm) is ranked higher than
98% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 26.60 vs. HLTH: 3.60 )
Ranked among companies with meaningful P/E(ttm) only.
HLTH' s P/E(ttm) Range Over the Past 10 Years
Min: 2.99  Med: 17.72 Max: 316.01
Current: 3.6
2.99
316.01
Forward P/E 9.39
HLTH's Forward P/E is ranked higher than
92% of the 87 Companies
in the Global Medical Care industry.

( Industry Median: 19.53 vs. HLTH: 9.39 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 3.60
HLTH's PE(NRI) is ranked higher than
98% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 26.14 vs. HLTH: 3.60 )
Ranked among companies with meaningful PE(NRI) only.
HLTH' s PE(NRI) Range Over the Past 10 Years
Min: 2.99  Med: 17.76 Max: 328.65
Current: 3.6
2.99
328.65
Price/Owner Earnings (ttm) 7.38
HLTH's Price/Owner Earnings (ttm) is ranked higher than
91% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 26.90 vs. HLTH: 7.38 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HLTH' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 3.54  Med: 17.51 Max: 610
Current: 7.38
3.54
610
P/B 1.52
HLTH's P/B is ranked higher than
78% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. HLTH: 1.52 )
Ranked among companies with meaningful P/B only.
HLTH' s P/B Range Over the Past 10 Years
Min: 0.26  Med: 2.41 Max: 13.43
Current: 1.52
0.26
13.43
P/S 0.72
HLTH's P/S is ranked higher than
76% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 1.64 vs. HLTH: 0.72 )
Ranked among companies with meaningful P/S only.
HLTH' s P/S Range Over the Past 10 Years
Min: 0.17  Med: 0.74 Max: 63.18
Current: 0.72
0.17
63.18
PFCF 79.46
HLTH's PFCF is ranked lower than
85% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 22.00 vs. HLTH: 79.46 )
Ranked among companies with meaningful PFCF only.
HLTH' s PFCF Range Over the Past 10 Years
Min: 0.4  Med: 7.13 Max: 99999999.99
Current: 79.46
0.4
99999999.99
POCF 23.59
HLTH's POCF is ranked lower than
70% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 14.40 vs. HLTH: 23.59 )
Ranked among companies with meaningful POCF only.
HLTH' s POCF Range Over the Past 10 Years
Min: 0.39  Med: 7.07 Max: 133.89
Current: 23.59
0.39
133.89
EV-to-EBIT 6.13
HLTH's EV-to-EBIT is ranked higher than
96% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 18.68 vs. HLTH: 6.13 )
Ranked among companies with meaningful EV-to-EBIT only.
HLTH' s EV-to-EBIT Range Over the Past 10 Years
Min: -2305.2  Med: 3.80 Max: 144.3
Current: 6.13
-2305.2
144.3
EV-to-EBITDA 5.18
HLTH's EV-to-EBITDA is ranked higher than
96% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 13.28 vs. HLTH: 5.18 )
Ranked among companies with meaningful EV-to-EBITDA only.
HLTH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -37.8  Med: 3.80 Max: 119
Current: 5.18
-37.8
119
Current Ratio 2.25
HLTH's Current Ratio is ranked higher than
80% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.36 vs. HLTH: 2.25 )
Ranked among companies with meaningful Current Ratio only.
HLTH' s Current Ratio Range Over the Past 10 Years
Min: 0.56  Med: 2.75 Max: 6.55
Current: 2.25
0.56
6.55
Quick Ratio 2.16
HLTH's Quick Ratio is ranked higher than
82% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. HLTH: 2.16 )
Ranked among companies with meaningful Quick Ratio only.
HLTH' s Quick Ratio Range Over the Past 10 Years
Min: 0.53  Med: 2.56 Max: 6.08
Current: 2.16
0.53
6.08
Days Inventory 133.49
HLTH's Days Inventory is ranked lower than
94% of the 168 Companies
in the Global Medical Care industry.

( Industry Median: 18.01 vs. HLTH: 133.49 )
Ranked among companies with meaningful Days Inventory only.
HLTH' s Days Inventory Range Over the Past 10 Years
Min: 16.82  Med: 26.43 Max: 1941.4
Current: 133.49
16.82
1941.4
Days Sales Outstanding 111.52
HLTH's Days Sales Outstanding is ranked lower than
94% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 42.74 vs. HLTH: 111.52 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLTH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.97  Med: 71.41 Max: 175.75
Current: 111.52
30.97
175.75
Days Payable 751.83
HLTH's Days Payable is ranked higher than
99% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. HLTH: 751.83 )
Ranked among companies with meaningful Days Payable only.
HLTH' s Days Payable Range Over the Past 10 Years
Min: 32.6  Med: 58.09 Max: 19118.01
Current: 751.83
32.6
19118.01

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.07
HLTH's Price/Tangible Book is ranked higher than
60% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 3.64 vs. HLTH: 3.07 )
Ranked among companies with meaningful Price/Tangible Book only.
HLTH' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.59  Med: 6.11 Max: 155
Current: 3.07
1.59
155
Price/Projected FCF 1.53
HLTH's Price/Projected FCF is ranked higher than
59% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. HLTH: 1.53 )
Ranked among companies with meaningful Price/Projected FCF only.
HLTH' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.05  Med: 0.26 Max: 5.31
Current: 1.53
0.05
5.31
Price/Median PS Value 1.00
HLTH's Price/Median PS Value is ranked higher than
65% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. HLTH: 1.00 )
Ranked among companies with meaningful Price/Median PS Value only.
HLTH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.3  Med: 1.05 Max: 68.33
Current: 1
0.3
68.33
Price/Graham Number 0.70
HLTH's Price/Graham Number is ranked higher than
95% of the 134 Companies
in the Global Medical Care industry.

( Industry Median: 2.76 vs. HLTH: 0.70 )
Ranked among companies with meaningful Price/Graham Number only.
HLTH' s Price/Graham Number Range Over the Past 10 Years
Min: 0.62  Med: 1.46 Max: 6.26
Current: 0.7
0.62
6.26
Earnings Yield (Greenblatt) (%) 16.23
HLTH's Earnings Yield (Greenblatt) (%) is ranked higher than
97% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. HLTH: 16.23 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HLTH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.7  Med: 21.40 Max: 118.4
Current: 16.23
0.7
118.4

More Statistics

Revenue (TTM) (Mil) $242.6
EPS (TTM) $ 0.66
Short Percentage of Float12.09%
52-Week Range $1.82 - 6.79
Shares Outstanding (Mil)76.78

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Dec16 Dec17 Dec18
Revenue (Mil $) 374 417 391
EPS ($) 0.33 0.48 0.45
EPS w/o NRI ($) 0.33 0.48 0.45
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for HLTH

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Nobilis Moves Forward with New President and New Canaccord Coverage Jul 20 2016
ETF’s with exposure to Nobilis Health Corp. : July 19, 2016 Jul 19 2016
5 Stocks Under $10 Set to Soar Jul 14 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 13 2016
Nobilis Names Kenneth Efird President Jul 11 2016
Nobilis to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference Jul 07 2016
ETF’s with exposure to Nobilis Health Corp. : July 5, 2016 Jul 05 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 30 2016
Nobilis Health Announces Results of 2016 Annual General Meeting of Shareholders Jun 28 2016
Nobilis Health Corp.: Sudden move in price, will it continue? Jun 22 2016
Nobilis Health (HLTH) in Focus: Stock Up 12.4% in Session Jun 22 2016
ETF’s with exposure to Nobilis Health Corp. : June 20, 2016 Jun 20 2016
ETF’s with exposure to Nobilis Health Corp. : June 3, 2016 Jun 03 2016
ImmuDyne Appoints Two Industry Leaders to Newly-Formed Business Development Advisory Board Jun 01 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... May 27 2016
Nobilis Announces Board Nominations for June 28th Shareholder Meeting May 26 2016
Nobilis Health Corp. :HLTH-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 May 26 2016
Nobilis Health's Kolin Ozonian Interviewed by The Life Sciences Report May 26 2016
Nobilis Health Corp. Announces Advance Notice Policy May 25 2016
NOBILIS HEALTH CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... May 23 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)